Addiction to prescription narcotics in the U.S. has reached epidemic proportions, contributing to the opioid crisis and becoming a major driver of drug diversion within healthcare settings. Diversion of drugs, for personal use or illegal distribution, can cause significant financial loss4 and potentially impact care to patients and staff safety.
As part of the BD HealthSight™ platform designed to support enterprise-wide medication management, the new BD HealthSight™ diversion management application is the next step in the company’s efforts to address drug diversion through integrated solutions and analytics. The product leverages data from existing BD products, including the BD Pyxis™ ES system, and the Electronic Medical Record (EMR) to provide actionable insights to assist with a hospital or health system’s diversion investigations.
Medication diversion is a growing and complex challenge for hospitals and health systems, requiring a holistic approach to medication management that includes a combination of connected technologies and robust analytics. Specific cases of diversion can be difficult to detect, and the impact can be devastating from a patient and healthcare worker safety standpoint. The new BD HealthSight diversion management application is designed to address the unique challenges associated with diversion by tracking patterns and risky behavior to help identify diverters as early as possible.”
